Monoclonal Antibodies for Diagnosing Epithelial Tumors
Author Information
Author(s): J. Cordell, T.C. Richardson, K.A.F. Pulford, A.K. Ghosh, K.C. Gatter, E. Heyderman, D.Y. Mason
Primary Institution: Nuffield Department of Pathology, University of Oxford
Hypothesis
Can monoclonal antibodies against human epithelial membrane antigen improve the diagnosis of epithelial tumors?
Conclusion
The monoclonal antibody E29 is effective for identifying tumors of epithelial origin and detecting metastases.
Supporting Evidence
- Antibody E29 reacted with a wide variety of human epithelial tissues.
- It was shown to be unreactive with normal squamous epithelium but reactive with neoplastic forms.
- Antibody E29 was capable of detecting micrometastases in lymph nodes.
- The antibody provided clearer labeling of human tissues compared to other antibodies.
- Reactivity of lymphomas with antibody E29 was rarely seen in a study of 120 tumor biopsies.
Takeaway
Scientists created special antibodies to help doctors find certain types of cancer in tissues, making it easier to diagnose.
Methodology
Monoclonal antibodies were produced by immunizing mice with epithelial membrane antigen and screening for reactivity against human tissues.
Potential Biases
Potential for misdiagnosis in cases where the antibody reacts with non-target cells, such as plasma cells.
Limitations
The study may not account for all types of tumors or variations in antibody reactions across different tissues.
Participant Demographics
Mice were used for antibody production; human tissues were sourced from hospitals.
Want to read the original?
Access the complete publication on the publisher's website